Morning Overview on MSN
A once-a-week insulin could replace the daily shots millions of diabetics rely on
For millions of people who manage diabetes with injected insulin, the daily needle is a fixed part of life. A new generation ...
LEHI, Utah, Oct. 16, 2025 /PRNewswire/ -- Non-profit pharmaceutical company Civica will launch an affordable long-acting insulin – insulin glargine-yfgn in pre-filled pens – at the lowest list price ...
HHS officials are moving forward with a plan to produce 4.8 million doses of H5N1 avian flu vaccine; Novo Nordisk’s long-acting insulin had a greater risk of excessively lowering patients’ blood sugar ...
Please provide your email address to receive an email when new articles are posted on . Two experts recently discussed situations in which ultra-long-acting insulins may be a good choice for patients ...
Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty of ...
Public News Service on MSN
California’s generic drug brand off to a slow start
By Angela Hart for KFF Health News. Broadcast version by Suzanne Potter for California News Service reporting for the KFF ...
Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...
Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit for ...
(Reuters) - The U.S. Food and Drug Administration on Friday approved Danish drugmaker Novo Nordisk's diabetes drug Tresiba, two years after rejecting the long-acting form of insulin. The agency also ...
What are insulin vapes? An endocrinologist explains how inhaled insulin works, how quickly it acts, its side effects and who ...
Indian drugmaker Mankind Pharma (NSE: MANKIND) has taken exclusive Indian rights to two insulin analogues developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results